Jean Stephane David: Faster Recognition of Thrombocytopenia in Severe Trauma
Jean Stephane David, Professor of Anesthesiology and Critical Care Medicine at Lyon University Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Thieme, adding:
“New publication in Thrombosis and Haemostasis (Thieme) !
Excited to share our latest work: ‘Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma.’
Thrombocytopenia is a major driver of trauma-induced coagulopathy, yet conventional platelet counts are too slow to guide early resuscitation decisions in the trauma bay.
This study explores whether the A5 Platelet parameter from ROTEM viscoelastic testing can serve as a fast, point-of-care surrogate to flag thrombocytopenia in severely injured patients — potentially helping clinicians make faster, better-informed transfusion decisions when every minute counts.
This work is the fruit of an excellent collaboration between our trauma team and the hemostasis team at our university hospital (CHU) — a great example of how close cooperation between clinical and laboratory expertise can move trauma care forward.
Congratulations to all co-authors involved in this project!”
Title: Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma
Authors: Jean Stephane David, Louise Sibille, Hamdi Rezigue, Jonathan Meltzer, Laurent Jallades, Marie-Odile Geay-Baillat, Christophe Nougier, Yesim Dargaud

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 07:39Better Trials and Better Treatments Through Greater Inclusion – American Society of Hematology
-
Sep 22, 2026, 07:18X. Long Zheng: From ADAMTS13 to New TTP Treatment
-
Sep 22, 2026, 07:11Platelet Dependent Protection Against Bacterial Pneumonia – JTH
-
Sep 22, 2026, 07:10Sumita Pandey: Apheresis Beyond Automation
-
Sep 22, 2026, 07:04Wafik El-Deiry: Type 1 interferon Alters Clonal Competition in Human Blood Development
-
Sep 22, 2026, 06:53Tania L.: Women in Hematology Take the Stage in Austin
-
Sep 22, 2026, 06:35Mahmoud Hanafy: Hayat National Hospitals Achieves AABB Accreditation
-
Sep 22, 2026, 06:01Nikola Pantic: New ASH ITP Guidelines Transform First-Line Treatment
-
Sep 22, 2026, 04:43Michael Cahillane: Highlights From BBTS2026 in Glasgow